| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.64 | 7e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-06 |